References
Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 39:191–214
Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death – apoptosis, autophagy and senescence. FEBS J 277:2–21
Hait WN, Hambley TW (2009) Targeted cancer therapeutics. Cancer Res 69:1263–1267
Wagner JM, Hackanson B, Lübbert M, Jung M (2010) Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics 1:117–136
Wang HC, Choudhary S (2011) Reactive oxygen species-mediated therapeutic control of bladder cancer. Nat Rev Urol 8:608–616
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Wang, HC.R. (2015). Bladder Cancer Molecular Therapy. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_7105-8
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_7105-8
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences